Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey
International Journal of Dermatology · 2026-12 · 65 (12) · 2617-2619
DOI: 10.1111/ijd.70586 ↗At a glance
Leserbrief in International Journal of Dermatology, published online on 2026-07-16. Written by Elika D Javaheri and 3 co-authors. Institution: Mayo Clinic Alix School of Medicine, Phoenix, Arizona, USA. Cited 1 times so far (Crossref); 4 references. Funded by: Mayo Clinic Arizona Department of Dermatology Residency Program.
Abstract (original language)
The data that support the findings of this study are available from the corresponding author upon reasonable request.
Subjects
Author keywords
Authors and institutions
- Mayo Clinic Alix School of Medicine, Phoenix, Arizona, USA.
- Department of Dermatology, Mayo Clinic, Scottsdale, Arizona, USA.
- Division of Clinical Trials and Biostatistics, Mayo Clinic, Scottsdale, Arizona, USA.
ORCID profiles: Elika D Javaheri
Funding
- Mayo Clinic Arizona Department of Dermatology Residency Program
Cite
APA
Javaheri, E. D., Godfrey, H., Yee, C., & Chen, S. X. (2026). Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey. International Journal of Dermatology, 65(12), 2617-2619. https://doi.org/10.1111/ijd.70586
Vancouver
Javaheri ED, Godfrey H, Yee C, Chen SX. Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey. International Journal of Dermatology. 2026;65(12):2617-2619. doi:10.1111/ijd.70586
BibTeX
@article{Javaheri2026,
author = {Javaheri, Elika D and Godfrey, Hannah and Yee, Claire and Chen, Stella X},
title = {Impact of GLP‐1 Receptor Agonists on Hidradenitis Suppurativa: A Cross‐Sectional Survey},
journal = {International Journal of Dermatology},
year = {2026},
volume = {65},
number = {12},
pages = {2617--2619},
doi = {10.1111/ijd.70586}
}
EUVIMED